<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03657953</url>
  </required_header>
  <id_info>
    <org_study_id>THA MIC</org_study_id>
    <nct_id>NCT03657953</nct_id>
  </id_info>
  <brief_title>Outcomes 8 Years After Minimal Invasive THA</brief_title>
  <official_title>Patient-relevant Outcomes 8 Years After Minimally Invasive Total Hip Replacement - a Randomized Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität Dresden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stryker Instruments</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Technische Universität Dresden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There exists only limited scientific evidence concerning medium- to long-term benefits
      concerning minimally invasive (MI) total hip arthroplasty (THA). The investigators examined
      in a randomized study design 157 patients 8 years after THA, which were performed via 3
      different surgical approaches.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In contrast to reported short-term advantages of minimally invasive (MI) total hip
      arthroplasty (THA) there exists only limited scientific evidence concerning medium- to
      long-term benefits.

      The investigators therefore sought to answer the following questions: Is the functional
      medium-term outcome in THA patients with MI-anterior(MI-A) and MI-anterolateral (MI-AL)
      approach superior to those treated by direct lateral approach (DLA)? Is the level of life
      quality increased by MI-THA? Is patient satisfaction higher by MI-THA? Is the revision rate
      reduced by MI-THA?
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2006</start_date>
  <completion_date type="Actual">September 30, 2015</completion_date>
  <primary_completion_date type="Actual">June 30, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>single-center prospective randomized study design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Physical function hip - Harris-Hip-Score (HHS)</measure>
    <time_frame>change from baseline (preoperative) at 8 years after THA</time_frame>
    <description>Harris-Hip-Score (worst=0, best=100)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical function hip - WOMAC</measure>
    <time_frame>change from baseline (preoperative) at 8 years after THA</time_frame>
    <description>WOMAC Total Score (worst=0, best=100)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction Level</measure>
    <time_frame>at 8 years after THA</time_frame>
    <description>Satisfaction scale (worst=0, best=10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health related Quality of life - Index</measure>
    <time_frame>change from baseline (preoperative) at 8 years after THA</time_frame>
    <description>EuroQol in 5 dimensions (EQ-5D) Index (worst=0, best=1)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health related Quality of life - VAS</measure>
    <time_frame>change from baseline (preoperative) at 8 years after THA</time_frame>
    <description>EQ-Visual Analogue Scale (worst=0, best=100)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity</measure>
    <time_frame>change from baseline (preoperative) at 8 years after THA</time_frame>
    <description>University of California, Los Angeles (UCLA) Activity Scale (worst=1, best=10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Revision rate</measure>
    <time_frame>at 8 years after THA</time_frame>
    <description>Revision rate using Kaplan-Meier-Survival Analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity Performance Test: walking</measure>
    <time_frame>change from baseline (preoperative) at 8 years after THA</time_frame>
    <description>25-meter walking time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity Performance Test: stair climbing</measure>
    <time_frame>change from baseline (preoperative) at 8 years after THA</time_frame>
    <description>5-step walking time</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">157</enrollment>
  <condition>Osteoarthritis, Hip</condition>
  <arm_group>
    <arm_group_label>anterior (MI-A) surgical approach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The minimally invasive anterior surgical approach was carried out using a modified Smith-Petersen access as described by Bender et al. (Bender et al. 2009) with the patient in supine position.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>anterolateral (MI-AL) surgical approach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For the minimally invasive anterolateral surgical approach, a modified Watson-Jones approach according to Röttinger (Rottinger et al. 2006) was applied with the patient in supine position.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>direct lateral (DLA) surgical approach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The direct lateral surgical approach was performed according to the technique described by Hardinge et al. (Hardinge et al. 1982) with the patient positioned supine</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>surgical approach</intervention_name>
    <arm_group_label>anterior (MI-A) surgical approach</arm_group_label>
    <arm_group_label>anterolateral (MI-AL) surgical approach</arm_group_label>
    <arm_group_label>direct lateral (DLA) surgical approach</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical and radiologic signs of advanced hip joint Degeneration

          -  Patients from age 18 to 75

        Exclusion Criteria:

          -  osteoporosis and

          -  osteomalacia,

          -  preceding surgery or radiation therapy in the proximity of the affected hip joint,

          -  progressive neoplasia,

          -  preceding or manifest infection of the affected joint and its surrounding soft
             tissues,

          -  rheumatoid arthritis,

          -  hip dysplasia Hartofilakidis type 2 or 3,

          -  non-compliance,

          -  chronic neurological or psychiatric diseases,

          -  ongoing pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maik Stiehler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Center for Orthopaedics and Trauma Surgery, University Hospital Carl Gustav</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Dresden, Orthopaedic Department</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>August 14, 2018</study_first_submitted>
  <study_first_submitted_qc>September 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2018</study_first_posted>
  <last_update_submitted>September 3, 2018</last_update_submitted>
  <last_update_submitted_qc>September 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Total Hip Arthroplasty</keyword>
  <keyword>minimally invasive</keyword>
  <keyword>Patient-relevant outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

